Skip to content

Mid-Term Radiological Outcomes of Femoral Neck Fractures Treated With Osteosynthesis: A Comparative Analysis

Mid-Term Radiological Outcomes of Femoral Neck Fractures Treated With Osteosynthesis: A Comparative Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06263309
Enrollment
10
Registered
2024-02-16
Start date
2022-06-01
Completion date
2023-09-01
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fractures, Femoral Neck Shortening

Brief summary

OBJECTIVES: This study assesses the efficacy of dynamic hip screw (DHS) versus cannulated screws for femoral neck fractures, focusing on femoral neck shortening, avascular necrosis (AVN) incidence, and functional outcomes. METHODS: Design: Retrospective cohort study. Setting: Academic Level I Trauma Center. Patient Selection Criteria: Included were patients with femoral neck fractures treated with DHS or cannulated screws, with follow-up data available. Outcome Measures and Comparisons: Main outcomes were femoral neck shortening, incidence of AVN, and Harris Hip Score (HHS) for functional assessment.

Interventions

DIAGNOSTIC_TESTFemoral neck shortening measurement

We examine femoral neck shortening in patients with femoral neck fractures.

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years

Inclusion criteria

* Patients aged 80 years and younger * Minimum of 2 years' follow-up * Diagnosed with a femoral neck fracture * Treated with either cannulated screws or a Dynamic Hip Screw (DHS).

Exclusion criteria

* Patients with multiple fractures in the same extremity * Presence of malignancy * Diagnosis of osteoporosis * Systemic inflammatory or metabolic diseases * Infection or malignancy in the hip joint * Insufficient medical records * Patients unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Harris Hip scoreminimum 2 yearsHip functional score

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026